Multi-institutional European experience of robotic thymectomy for thymoma

  • Giuseppe Marulli*
  • , Jos Maessen
  • , Franca Melfi
  • , Thomas A. Schmid
  • , Marlies Keijzers
  • , Olivia Fanucchi
  • , Florian Augustin
  • , Giovanni M. Comacchio
  • , Alfredo Mussi
  • , Monique Hochstenbag - Brands
  • , Federico Rea
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Robotic thymectomy for early-stage thymomas has been recently suggested as a technically sound and safe approach. However, due to a lack of data on long term results, controversy still exists regarding its oncological efficacy. In this multi-institutional series collected from four European Centres with high volumes of robotic procedures, we evaluate the results after robot-assisted thoracoscopic thymectomy for thymoma. Methods: Between 2002 and 2014, 134 patients (61 males and 73 females, median age 59 years) with a clinical diagnosis of thymoma were operated on using a left-sided (38%), right-sided (59.8%) or bilateral (2.2%) robotic approach. Seventy (52%) patients had associated myasthenia gravis (MG). Results: The average operative time was 146 minutes (range, 60-353 minutes). Twelve (8.9%) patients needed open conversion: in one case, a standard thoracoscopy was performed after robotic system breakdown, and in six cases, an additional access was required. Neither vascular and nerve injuries, nor perioperative mortality occurred. A total of 23 (17.1%) patients experienced postoperative complications. Median hospital stay was 4 days (range, 2-35 days). Mean diameter of resected tumors was 4.4 cm (range, 1-10 cm), Masaoka stage was I in 46 (34.4%) patients, II in 71 (52.9%), III in 11 (8.3%) and IVa/b in 6 (4.4%) cases. At last follow up, 131 patients were alive, three died (all from non-thymoma related causes) with a 5-year survival rate of 97%. One (0.7%) patient experienced a pleural recurrence. Conclusions: Our data suggest that robotic thymectomy for thymoma is a technically feasible and safe procedure with low complication rates and short hospital stays. Oncological outcome appears to be good, particularly for early-stage tumors, but a longer follow-up period and more cases are necessary in order to consider this as a standard approach. Indications for robotic thymectomy for stage III or IVa thymomas are rare and should be carefully evaluated.
Original languageEnglish
Pages (from-to)18-25
Number of pages8
JournalAnnals of Cardiothoracic Surgery
Volume5
Issue number1
DOIs
Publication statusPublished - Jan 2016

Keywords

  • Thymoma
  • robotic thymectomy
  • early stage thymoma
  • myasthenia gravis (MG)
  • thoracoscopy

Fingerprint

Dive into the research topics of 'Multi-institutional European experience of robotic thymectomy for thymoma'. Together they form a unique fingerprint.

Cite this